Lin NU - Search Results

1

Acquired HER2 mutations in ER⁺ metastatic breast cancer confer resistance to estrogen receptor-directed therapies.

Nayar U, Cohen O, Kapstad C, Cuoco MS, Waks AG, Wander SA, Painter C, Freeman S, Persky NS, Marini L, Helvie K, Oliver N, Rozenblatt-Rosen O, Ma CX, Regev A, Winer EP, Lin NU, Wagle N. Nayar U, et al. Among authors: lin nu. Nat Genet. 2019 Feb;51(2):207-216. doi: 10.1038/s41588-018-0287-5. Epub 2018 Dec 10. Nat Genet. 2019. PMID: 30531871

2

New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors.

Lin NU, Winer EP. Lin NU, et al. Breast Cancer Res. 2004;6(5):204-10. doi: 10.1186/bcr919. Epub 2004 Jul 29. Breast Cancer Res. 2004. PMID: 15318926 Free PMC article. Review.

3

CNS metastases in breast cancer.

Lin NU, Bellon JR, Winer EP. Lin NU, et al. J Clin Oncol. 2004 Sep 1;22(17):3608-17. doi: 10.1200/JCO.2004.01.175. J Clin Oncol. 2004. PMID: 15337811 Review.

4

Dose density in breast cancer: a simple message?

Lin NU, Gelman R, Winer EP. Lin NU, et al. J Natl Cancer Inst. 2005 Dec 7;97(23):1712-4. doi: 10.1093/jnci/dji438. J Natl Cancer Inst. 2005. PMID: 16333021 No abstract available.

5

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.

Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L. Harris LN, et al. Among authors: lin nu. Breast Cancer Res. 2006;8(6):R66. doi: 10.1186/bcr1622. Breast Cancer Res. 2006. PMID: 17129383 Free PMC article. Clinical Trial.

6

Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.

Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LN. Lin NU, et al. Invest New Drugs. 2007 Aug;25(4):369-75. doi: 10.1007/s10637-007-9034-y. Epub 2007 Mar 8. Invest New Drugs. 2007. PMID: 17345004 Clinical Trial.

7

Tumor therapeutic response and vessel tortuosity: preliminary report in metastatic breast cancer.

Bullitt E, Lin NU, Ewend MG, Zeng D, Winer EP, Carey LA, Smith JK. Bullitt E, et al. Among authors: lin nu. Med Image Comput Comput Assist Interv. 2006;9(Pt 2):561-8. doi: 10.1007/11866763_69. Med Image Comput Comput Assist Interv. 2006. PMID: 17354817 Free PMC article. Clinical Trial.

8

Brain metastases: the HER2 paradigm.

Lin NU, Winer EP. Lin NU, et al. Clin Cancer Res. 2007 Mar 15;13(6):1648-55. doi: 10.1158/1078-0432.CCR-06-2478. Clin Cancer Res. 2007. PMID: 17363517 Review.

9

Optimal use of aromatase inhibitors: to lead or to follow?

Lin NU, Winer EP. Lin NU, et al. J Clin Oncol. 2007 Jul 1;25(19):2639-41. doi: 10.1200/JCO.2007.10.9447. Epub 2007 Jun 11. J Clin Oncol. 2007. PMID: 17563391 No abstract available.

10

Heterogeneity of breast cancer and implications of adjuvant chemotherapy.

Razzak AR, Lin NU, Winer EP. Razzak AR, et al. Among authors: lin nu. Breast Cancer. 2008;15(1):31-4. doi: 10.1007/s12282-007-0007-y. Breast Cancer. 2008. PMID: 18224391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters